Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring

Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are placing greater pressure on laboratory operations, potentially disrupting testing and delaying patient care. To support earlier recognition of these problems, researchers have developed an AI framework designed to identify emerging operational issues.

Researchers at Weill Cornell Medicine (New York, NY, USA) have designed Laboratory Agentic Reasoning and Integrative Analytics (LabARIA), an artificial intelligence (AI) framework for clinical laboratory quality and operations. Presented as one of the first frameworks to use multiple specialized AI tools, or agents, for laboratory monitoring, LabARIA aims to integrate capabilities currently fragmented across task-specific AI applications in laboratory medicine.

Image: Key modules and interactions in the LabARIA agentic system. (Yang, H.S., Pan, W., Cushing, M.M. et al. An agentic framework for intelligent clinical laboratory medicine. npj Health Systems (2026). https://doi.org/10.1038/s44401-026-00163-3)

The proposed framework would connect to existing laboratory information systems and other databases. A central AI data coordinator would route information to specialized agents monitoring specimen quality, testing turnaround times, analytical quality control, instrument performance, and regulatory compliance. Additional agents would forecast inventory and staffing needs. Built-in accountability would provide traceable data records and explanations for recommendations, allowing laboratory professionals to override the system when needed.

These capabilities could complement current practices, in which staff perform checks several times daily and retrospectively troubleshoot analytical issues when results violate established quality-control rules. LabARIA could identify concerning trends before formal violations occur, including changes associated with reagents or other testing materials. It could also detect patterns in specimen-quality indicators linked to collection, handling, or transportation, prompting investigation before testing disruptions delay result reporting.

The framework was outlined in a perspective published October 28 in npj Health Systems, with work involving Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. LabARIA remains conceptual, and the team plans to conduct experiments using retrospective laboratory data to refine the system. No clinical performance metrics or patient cohort size were reported.

“This framework can identify anomalies and pull data together to help lab personnel investigate and address problems earlier. Improving laboratory quality and efficiency with AI can benefit health care delivery,” said Dr. He Sarina Yang, associate professor of clinical pathology and laboratory medicine at Weill Cornell and medical director of the clinical chemistry and toxicology laboratory at NewYork-Presbyterian/Weill Cornell Medical Center. 

“Once we've got convincing evidence, we can discuss implementing the system in our clinical lab. Even after deployment, we will continue to monitor the system to make sure it is running securely and effectively,” said Dr. Fei Wang, associate dean for artificial intelligence and the Frances and John Loeb Professor of Medical Informatics in the Department of Population Health Sciences at Weill Cornell.

Related Links
Weill Cornell Medicine